Metabolic factors associated with benign prostatic hyperplasia
about
The impact of obesity towards prostate diseasesHyperglycemia and insulin resistance and the risk of BPH/LUTS: an update of recent literatureSerum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.Finasteride reduces the risk of incident clinical benign prostatic hyperplasiaVentral prostate fibrosis in the Akita mouse is associated with macrophage and fibrocyte infiltration.Progression of lower urinary tract symptoms in older men: a community based study.Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor networkBenign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.Benign prostatic hyperplasia: from bench to clinicRisk of cancer in a large cohort of U.S. veterans with diabetes.5α-reductase type 1 modulates insulin sensitivity in men.Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study.Community-based research on the benign prostatic hyperplasia prevalence rate in Korean rural area.Relationship between metabolic syndrome and prostate volume in Korean men under 50 years of age.Linking pre-diabetes with benign prostate hyperplasia. IGFBP-3: a conductor of benign prostate hyperplasia development orchestra?Associations between modest weight changes and onset and progression of lower urinary tract symptoms in two population-based cohorts.Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention.Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels.PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.Lower urinary tract symptoms in men.Can metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)?Waist circumference and risk of lower urinary tract symptoms: a meta-analysis.Prevalence and trends of urinary incontinence in adults in the United States, 2001 to 2008Towards the prevention and management of prostatic diseases in Nigeria: a framework.Association of metabolic syndrome and benign prostate enlargement in young korean males.Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study.Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.Relationship between Metabolic Syndrome and Lower Urinary Tract Symptoms: Hallym Aging Study.Benign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat modelDoes Inflammation Mediate the Obesity and BPH Relationship? An Epidemiologic Analysis of Body Composition and Inflammatory Markers in Blood, Urine, and Prostate Tissue, and the Relationship with Prostate Enlargement and Lower Urinary Tract Symptoms.Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation.Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume.Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study.Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate sizeAge and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia.NF-κB and androgen receptor variant expression correlate with human BPH progressionChallenging the Inevitability of Prostate Enlargement: Low Levels of Benign Prostatic Hyperplasia Among Tsimane Forager-Horticulturalists
P2860
Q26750847-41A90C40-790C-4E09-91C9-11E1712EC4D4Q27011347-3678F86B-BBCF-4D70-B113-3DC0E58175B5Q33725858-D03DDC42-3B3D-4A33-85BE-544687FC7C42Q33762340-A440560C-7DD2-4303-A4D4-F895B6A0737FQ33820772-EF5BD98F-0FE2-4CFB-8ADC-E98501AF187BQ33958191-B42F4636-3CE4-48DA-A60A-3B48AB637688Q34163024-628534DD-2E88-4203-8001-B3CCC17EC7EEQ34176834-47C3E8B4-333A-407F-B7DF-FA0F7297AFB2Q34216723-DE37368A-1689-43F9-BCDA-622FE8DC1629Q34234264-84F43964-86A4-43B7-B0BE-B40985A1EFE9Q34396472-45BAB992-A6A7-48B3-BAD7-1AA9FF16FC9CQ34442391-127456DC-309B-4924-A1B2-A711186B407CQ34535741-C4182009-D4AC-4230-9768-2E051BFE13E8Q34591489-AB0DC5A8-B312-4936-8FFC-CA1BF2803723Q34962509-A84992F8-7365-43AF-8BF6-AADE141F6A09Q35070014-92E58280-CFDF-4685-B54B-E4C3EDB54894Q35075205-993F4A67-381D-4469-8351-5F0B98AEF844Q35154271-D2C616D1-CBBC-494F-83CA-D086AE3DAF42Q35182377-CF2731CB-C57D-4663-AF74-07823E375F07Q35214163-01C25CE2-E6F4-4FEC-88AA-E2B6497D5182Q35216293-AF93A97D-CD2D-4036-87A3-82E7DC8F0D06Q35225398-55EA4E7F-1E2D-41D2-94DB-8A90F55A0AA5Q35228167-CAFEBB4F-C3CC-423E-A1B5-12E65F1294EEQ35312593-5906D26E-2338-47BA-8D49-2D7B5FE13671Q35394236-E2952E16-151A-41C4-88D4-3C92164F99A5Q35550448-FC93CD6D-9511-477A-B1B5-98B8A24130ECQ35624518-58C1C43D-7113-4EDB-9933-E1A41FF64D91Q35632649-FCEC40D1-6297-4B98-AB66-338A959139E9Q35687087-37855339-C330-4F46-AD7C-040A2D295E0AQ35823776-E8498CF1-A8A4-404F-9ACA-075F27E72571Q35843929-5FC77844-EE1B-48CE-836B-69DB75DC92D2Q36059979-EA505587-1B69-400F-A398-9CBBE4008FC7Q36080363-27C9426C-4CB1-4A7A-9ADA-C953BA9E2169Q36211459-D3E32DDE-2C00-47CD-BFC9-62FD5DB6CF0CQ36284900-42101C3B-845A-4852-B307-39968019E24FQ36334566-3EB1E35D-D88B-4CA7-8D84-C656CCACE085Q36442301-54EF1FCE-DFA3-48C8-9A08-57C74AE3104CQ36602183-9FE46DC4-4DE8-4304-9D4E-9689E7E5D8EDQ36606285-1DAE2DCC-E49C-4C19-A91D-02C6CCF7F407Q36853498-3D42B9C5-6F33-4B9C-A182-BBE2B6DF8EC9
P2860
Metabolic factors associated with benign prostatic hyperplasia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 April 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic factors associated with benign prostatic hyperplasia
@en
Metabolic factors associated with benign prostatic hyperplasia.
@nl
type
label
Metabolic factors associated with benign prostatic hyperplasia
@en
Metabolic factors associated with benign prostatic hyperplasia.
@nl
prefLabel
Metabolic factors associated with benign prostatic hyperplasia
@en
Metabolic factors associated with benign prostatic hyperplasia.
@nl
P2093
P2860
P356
P1476
Metabolic factors associated with benign prostatic hyperplasia
@en
P2093
B Gwen Windham
E Jeffrey Metter
Elizabeth A Platz
H Ballentine Carter
J Kellogg Parsons
Luigi Ferrucci
Patricia Landis
P2860
P304
P356
10.1210/JC.2005-2799
P407
P577
2006-04-11T00:00:00Z